СПИСОК ЛИТЕРАТУРЫ

1. Боровиков В.П./ STATISTICA: искусство анализа данных на компьютере. Для профессионалов. Боровиков В.П.//Санкт-Петербург- 2001. -С.656.

2. Боярский К.Ю. /Современный взгляд на проблему рецептивности и тонкого эндометрия в программах ВРТ.

3. Быстрова О.Б./Способы восстановления фертильности у онкологических больных. Быстрова О.Б., А.С. Калугина // Practical oncology. Т. 10-№ 4 - 2009- С.249-253.

4. Джамбор В. В. /Усовершенствование программы экстракорпорального оплодотворения человека с помощью применения метода витрификации. Джамбор В. В. /Автореф. дис. ... канд. биол. наук. М.; 2005.-С.40.

5. Дисаи Ф.Дж./Клиническая онкогинекология. Перевод с английского под редакцией Новиковой Е.Г. Дисаи Ф.Дж., Крисман У.Т. // Москва.-Рид Элсивер.-2012. -Том 3.-С .161-207.

6. Исмайлова М.К./Эктопическая беременность после

экстракорпорального оплодотворения. Исмайлова М.К. // Практическая медицина. -№7.- Стр. 161-162.

7. Калинина Е.А. /Программа оптимизации ЭКО и переноса эмбрионов в полость матки у пациентов в синдромом поликистозных яичников (клинические и эмбриологические аспекты). Калинина Е.А.// Дис.:док.мед.наук. М.-2002-С.42.

8. Калугина А.С./ Влияние качества полученных эмбрионов на исходы программ криоконсервации при сравнении методов медленного замораживания и витрификации в циклах ВРТ. Калугина А.С., Кравчук Я.Н., Шлыкова С.А.// Журнал акушерства и женских болезней Санкт- Петербург. -2012- LXI(4)-C48-53.

9. Кетиладзе Т.М./Синдром гиперстимуляции яичников: лечение и профилактика. Кетиладзе Т.М., Овсянникова Т.В., Алексеева М.Л., // Проблемы репродукции .-1999. -№2. -С.52-55

10. Козлова А.Ю. /Особенности фолликулогенеза при различных схемах

стимуляции суперовуляции с помощью обычного чМГ и

рекомбинантного ФСГ у пациенток программы ЭКО и ПЭ.

11. Комиссарова Ю.В., Гарданова Ж.Р. /Прогнозирование и профилактика синдрома гиперстимуляции яичников. Вестник новых медицинских технологий. Комиссарова Ю.В., Гарданова Ж.Р. //.-2007- Т. XIV.- №3. С. 8.

12. Краснопольская К.В./Сохранение репродуктивной функции у женщин с онкологическими заболеваниями (клиническая лекция). Краснопольская

К.В., Назаренко Т.А. //Онкогинекология. №3. -2012. -С.66-73.

13. Краснопольская К.В. /Экстракорпоральное оплодотворение в

комплексном лечении женского бесплодия. Краснопольская К.В.// Дисс.докт. мед. Наук - 2003. -С. 304.

14. Кузнецова Н.А./Синдром гиперстимуляции яичников.//2005.- http: //gynecolog.net/content/view/1472/36.

15. Кузьмичев Л.Н./Исследование эффективности и безопасности депо- форм а-Г нРГ бусерелина и трипторелина в программе ЭКО. Кузьмичев Л.Н., Яворовская К.А., Дьяконов С.А. // Проблемы репродукции, - 2005.- № 4.-С. 19-21.

16. Кулаков В.И. /Вспомогательные репродуктивные технологии - настоящее и будущее. Кулаков В.И. // Лечение женского и мужского бесплодия.М- Медицинское Информационное Агенство. - 2005. - С. 11-22.

17. Кулаков В.И. и др. / Акушерство и гинекология.//- 2006.- № 4.- С. 40

45.

18. Курцер М.А./ Перинатальные исходы у пациенток после ЭКО. Курцер М.А., Краснопольская К.В., Ероян Л.Х.// Акушерство и гинекология.-№ 2.-С.60-61.

19. Кэй Элдер./Экстракорпоральное оплодотворение. Кэй Элдер,Брайан Дэйл . // Медпресс .Москва.-2008.- С.17-21.

20. Линде В.А./Синдром гиперстимуляции яичников. Линде В.А., Добровольский М.С., Иванов А.В.// Санкт-петербург.-2007.-с.39-40.

21. Манушарова P.A., Черкезова Э.И./ Комплексное лечение эндометриоза с применением аналога гонадотропин-рилизинг-гормона и рилизинг- системы Мирена. М. Манушарова P.A., Черкезова Э.И.// Гинекология.- 2.-Т.7.- 2005.

22. Назаренко Т.А. /Стимуляция функции яичников 3-е изд.,-доп. Назаренко Т.А.//М.:МЕДпресс-информ.-2011.-С.93-95.

23. Назаренко Т.А./ Женское бесплодие, обусловленное нарушениями процесса овуляции: клиника, диагностика, лечение.

24. Назаренко Т.А./Особенности лечения бесплодия у пациенток с синдромом поликистозных яичников, в том числе с помощью ЭКО. Назаренко Т.А., Гаспаров A.C., Кузьмичев JI.H. и др // Экстракорпоральное оплодотворение и его новые направления в

лечении женского бесплодия.М- Медицинское Информационное Агенство.- 2000.- С.470- 496.

25. Никитин А.И. /Факторы неудач в программах вспомогательной репродукции. Никитин А.И. //Пробл. репрод.- 1995.-№2.-С.36-42.

26. Никитин А.И., Воробьева О.А., Китаев Э.М. /Эндокринная регуляция фолликуло- и гаметогенеза. Эндокринология репродукции.// Спб.: Наука.-1991г.-С.80-117.

27. Носкова Ю.О./Мультипротекторная витрификация ооцитов. Создание и использование криобанка ооцитов доноров: опыт Клиники МАМА. Носкова Ю.О., Кривохарченко И.С., Захарова Е.Е., Залетова В.В.// Проблемы репродукции.-2011.- №6.-С.46-50.

28.О.В. Быстрова/Способы восстановления фертильности у онкологических больных. О.В. Быстрова, А.С. Калугина, Е.В. Цыбатова, Н.И. Тапильская,Ю.В. Диникина, А.С. Лисянская, Г.М. Манихас. // Practical oncology. -Т. 10.-№ 4 - 2009-С.249-253.

29. Реброва О.В./ программа «Статистика». Реброва О.В.// М.: Медиа Сфера.-2002. - С.380.

30. ^bo A.. /Use ofcryo-bankedoocytes in anovum donation programme: a prospective, randomized, controlled, clinical trial. ^bo A., Meseguer M., Remohi J.,PellicerA. //Hum. Reprod.- 2010. Level I .-25.-С.2239-2246.

31. Сидорова И.С./Клинико- морфологические особенности эндометриоза яичников. Сидорова И.С., Коган Е.А.. Унанян А.Л., Гуриев Т.Д. // Акуш. и гинекол,- 2005 -№ 6,.-С.43-48.

32. Сметник В .П. /Агонисты ГнРГ и «возвратная» (Add back) терапия. Сметник В .П., Долгова И.А. // Проблемы репродукции.- 1999 г.,.-т.5.- № 6.- С.22-24.

33. Сметник В.П. /Использование аналогов ГнРГ в репродуктологии и онкологии. Сметник В.П., Чернуха Г.Е., Самойлова Т.Е. // Проблемы репродукции. - 2003.- №5.- С.28-32.

34. Сметник В.П. /Неоперативная гинекология.

35. Смирнова A.A. /Прогнозирование исхода индукции овуляции гонадотропинами у пациенток с синдромом поликистозных яичников. Смирнова A.A., Назаренко Т.А., Чечурова Т.Н. // Проблемы репродукции.- 2004,- т. 10.- № 4.- С.21-29.

36. Смирнова А.А./Криоконсервация ооцитов человека: клинические исходы. Смирнова А.А., Тур-Каспа И. // Проблемы репродукции.-

2005.-№1.-С. 14-18.

37. Смольникова В.Ю./ Изучение особенностей действия а-ГнРг-депо декапептила и нафарилина в программе ЭКО и ПЭ. Смольникова В.Ю.// Дис..канд.мед.наук. -М., 1995.

38. Таскина, О. А./ Сравнительная эффективность препаратов аналогов

агнониста гонадотропин-рилизинг-гормона (диферелина и лейпрорелина) в циклах ЭКО у пациенток с синдромом гиперстимуляции яичников в период после трансвагинальной пункции. Таскина, О. А. //Вестник новых медицинских технологий:

периодический теоретический и научно-практический журнал. - 2007. - Том 14,.-№ 3. - С. 9-10.

39. Финогенова Е.Я. /Принципы реализации метода ЭКО и переноса эмбрионов у бесплодных супружеских пар. Финогенова Е.Я.// Дис..канд.мед. наук.-М.,1998.

40. Abdel Gadir A./ Ovarian electrocautery versus human menopausal gonatrophins and pure follicle-stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Abdel Gadir A., Mowafi R.S.// Clin. Endocrinol. 1990.-3.-С.585-592.

41. Aboulghar, M. / Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome [Text] M. Aboulghar, J.H. Evers, H. Al-Inany // Cochrane Database Syst Rev. - 2000. - Vol. 2:CD001302.

42. Aflan M. /Statistically significant increase births with hMG in IVf and ICSI cycles versus rFSH: results from systematic review. Aflan M., Coomarasamy A., Van Wely M., et al //Hum Reprod. 2007;22:Suppl:1:Abstract:O-098.i.39.

43. Albuquerque L. E./Depot versus daily administration of gonadodtrophin realizing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.

44. Alikani M./ Human oocyte and embryo cryopreservation. Curr. Opin. Alikani M., Cohen J.// Obstet. Gynecol. 1990; 5(2): 714-7.

45. Al-Inany H./ GnRH antagonists are safer than agonists: an update of a Cochrane review [Text] H. Al-Inany, A. Abou-Setta, M. Alboulghar et al.// Hum Reprod Update. - 2011. - Vol. 17(4).-P. 435.

46. Al-Inany H.G. /Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Al-Inany H.G., Abou-Setta A.M., Aboulghar M.//Reprod. Biomed. Online. 2007.-14:640-649. doi: 10.1016/S1472- 6483(10)61059-0.

47. Al-Inany H.G./Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Al-Inany H.G., Abou-Setta A.M., Aboulghar M. //Reprod.Biomed.Online. 2007.-14.-640-649. doi: 10.1016/S1472- 6483(10)61059-0

48. Almodin C.G., Minguetti-Camara VC, Paixao CL, Pereira PC. /Embryo development and gestation using fresh and vitrified oocytes. Almodin C.G., Minguetti-Camara VC, Paixao CL, Pereira PC. // Hum. Reprod. 2010.- VOL.25.-P. 1192-1198.

49. Andersen A. /Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE. Andersen A., Gianaroli L., Nygren K. // Hum. Reprod. 2004.-VOL.19.-P.490—503.

50. Andersen A./Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE. Andersen A., Gianaroli L., Nygren K. //Hum. Reprod. 2004.-VOL.19.-P.490—503

51. Antinori M. /Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Antinori M., Licata E., Dani G., Cerusico F., Versaci C., Antinori S. //Reprod. Biomed. Online 2007.-14.-P.72-9.

52. Antonio Requena /Evaluation of the degree of satisfaction in oocyte donors using sustained-release FSH corifollitropin . Antonio Requena , Mari'a Cruz , Diana Collado , Alexandra Izquierdo ,Agusti'n Ballesteros , Manuel Mun~oz , Juan Antonio Garci'a-Velasco.// Reproductive BioMedicine Online.-2013.-26.-P.253- 259

53.

54. Balaban B. /A randomized controlled study of human day 3 embryo cryopreservation by slow freezing or vitrification: vitrification is associated with higher survival, metabolish and blastocyst formation. Balaban B. // Hum. Reprod. 2008.- 23 (9).-P.1976-1982.

55. Balaban B./ Effect of oocyte morphology on embryo development and implantation. Balaban B., Urman B. // Reproductive Biomedicine Online.2006.- 12(5).-P. 608-615.

56. Battaglia C./Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Battaglia C., Genazzani A. //Fertil.Steril. 2000.-74.-Т. 4.-P.809-812.

57. Beckers N.G./First live birth after ovarian stimulation using a chimeric long- acting human recombinant follicle-stimulating hormone ( FSH) agonist (resFSH-CTP) for in vitro fertilization. Beckers N.G., Macklon N.S. Devroy P.et al// Fertile.Steril.2003.-79(3).-P.621-623.

58. Bedoschi G.M./Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. Bedoschi G.M., de Albuquerque F.O., Ferriani R.A., Navarro P.A.// J. Assist. Reprod. Genet. 2010.-27(8).-P.491-494.

59. Benadiva C.A./ Clomiphene citrate and hMG^A An alternative stimulation protocol for selected failed in vitro fertilization patients. Benadiva C.A., Davis O., Kligman I. et al.// J.Assist.Reprod.Genet.1995.-P. 12-18.

60. Berlanga O./How endometrial secretomics can help in predicting implantation. Berlanga O., Bradshaw H.B., Vilella-Mitjana F., Garrido- Gomez T.,Simon C. //Placenta. 2011.- Vol.32: 3.-P. 271—275.

61. Bernard A./Cryopreservation of human oocytes: a review of current problems and perspectives. Bernard A., Fuller B.J. // Hum. Reprod. Update. 1996.- 3 (2).- P.193-207.

62. Bidet M. /Premature ovarian failure: predictability of intermittent ovarian function and response to ovulation induction agents. Bidet M. Bachelot A. Touraine P. //Curr.Opin.Obstet. Gynecol. 2008.-Vol.20.-P.416-420.

63. Bjercke S., Fedorcsak P., Abyholm T. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.// Hum. Reprod.,-2005, Vol.20, No5, pp.1200-1206.

64. Blumenfeld Z. /Prevention of gonadal damage during cytotoxic therapy. Blumenfeld Z., Haim N. // Ann. Med. — 1997. — Vol. 29. — n3. — P. 199206.

65. Boiso I./ A confocal microscopy analysis of the spindle and chromosome configurations of human oocytes cryopreserved at the germinal vesicle and metaphase II stage. Boiso I., Marti M., Santalo J. et al. // Hum. Reprod. 2002/-Vol. 17.-P. 1885-1891.

66. Brinsden Ed. P. / A textbook of in vitro fertilization and assisted reproduction. Brinsden Ed. P, Rainsbury P. // The Parthenon Publishing Group.-1992.

67. Cao Y.X./Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification. Cao Y.X., Xing Q., Li L., Cong L., Zhang Z.G., Wei Z.L. et al. // Fertil. Steril. 2009.-Vol.92.- P.1306-1311.

68. Chang C.C. /Human oocyte vitrification: in-vivo and in-vitro maturation outcomes. Chang C.C., Shapiro D.B., Bernal D.P., Wright G., Kort H.I., Nagy Z.P.// Reprod. Biomed. Online 2008.-Vol.-17.-P.684-688.

69. Chen C. /Fertillising capacity of frozen human spermatozoa. Chen C.// nature.1953-vol.172-p.767.

70. Chen C./ Diffusion controlled ice growth with soft impingement inside biological cells during freezing. Chen C., Li W.// Cryo Letters.- 2008.-Vol. 5(29).-P.371-381.

71. Chen S.U., Lien Y.R., Chao K., Lu H.F., Ho H.N., Yang Y.S./Cryopreservation of mature human oocytes by vitrification with ethylene glycol in straws.// Fertil. Steril.- 2000.-Vol.74.-P.804-808.

72. Chian R.C. /High Survival Rates and Pregnancies of Human Oocytes Following Vitrification: Preliminary Report. Chian R.C., Son W.Y., Huang J.Y., Cui S.J, Buckett W.M., Tan S.L. // Fertil. Steril.- 2005.VoL.84.-P.36.

73. Chian R.C./ In_vitro maturation of human oocytes/ Chian R.C., Buckett W.M., Tan S.L./ // Reprod. Biomed. Online. - 2004. - Vol.8. -P.148-166.

74. Chian R.C./Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Chian R.C., Huang J.Y.H., Tan S.L., Lucena E., Saa A., Rojas A., Castellon L.A.R., Amador M.I.G., Sarmiento J.E.M. // Reprod. Biomed. Online 2008.-Vol.16.-P.608-610.

75. Chian R.C./Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Chian R.C., Huang J.Y., Gilbert L. et al. // Fertil. Steril. - 2009. - Vol.91. - №6. - P.2391-2398.

76. Cobo A. / New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Cobo A., Bellver J., Domingo J., Perez S., Crespo J., Pellicer A. et al //Reprod. Biomed. Online 2008.-Vol.17.-P.68-72.

77. Cobo A. / Oocyte cryopreservation for donor egg banking IVI. Cobo A. , Jose' Remohi' , Ching-Chien Chang , Zsolt Peter Nagy //Valencia, Plaza de la Polici'a Local 3, 46015 Valencia, Spain; Reproductive Biology Associates, 1150 Lake Hearn Dr., Suite 600, Atlanta, GA 30342, USA. Reproductive BioMedicine Online (2011) 23.-P.341- 346.

78. Cobo A. / Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Cobo A., Domingo J., Perez S., Crespo J., Remohi J., Pellicer A.//Clin. Transl. Oncol. 2008.-Vol.10.-P. 268—273.

79. Cobo A. /Clinical application of oocyte vitrification:a systematic review and meta-analysis of randomized controlled trials. Cobo A. Diaz C./ // Fertil. Steril. — 2011. — Vol. 96. —P. 277-285.

80. Cobo A. /Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Cobo A., Kuwayama M., Perez S., Ruiz A., Pellicer A., RemoM J.// Fertil. Steril. 2008.-Vol.89.-P.1657-1664.

81. Cobo A. /Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Cobo A., Kuwayama M., Perez S., Ruiz A., Pellicer A., Remohi J. // Fertil. Steril. 2008.-Vol.89.-P.1657.- Level I.

82. Cobo A. /Oocyte vitrification: a useful perspective in assisted. Cobo A. // Unit at IVI. Valencia; 2011.

83. Cobo A. /Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Cobo A., Domingo J., Perez S., Crespo J., Remohi J., Pellicer A. // Clin. Transl. Oncol. -2008.-Vol.10.-P.268-273.

84. Cobo A. /Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Cobo A., Domingo J., Perez S., Crespo J., Remohi J., Pellicer A. // Clin. Transl.col. - 2008.-Vol.10.-P.268-273.

85. Cobo A., Remohi J., Chang C.C., Nagy Z.P. /Oocyte cryopreservation for donor egg banking. Cobo A., Remohi J., Chang C.C., Nagy Z.P. // Reprod. Biomed. Online. 2011.-Vol. 23.-P. 341-346.

86. Cobo A., Romero J.L., Perez S., de los Santos M.J., Meseguer M., Remohi J. /Storage of human oocytes in the vapor phase of nitrogen. Cobo A., Romero J.L., Perez S., de los Santos M.J., Meseguer M., Remohi J. // Fertil. Steril. 2010.

87. Cobo A./ Oocyte vitrification: a useful perspective in assisted.// Unit at IVI, Valencia. Spain.- 2011.

88. Cobo A./Higest liquid nitrogen quality for vitrification process : micro bacteriological filtration of LN2. In book: 16th World Congress on In vitro fertilization; 6th World Congress on In Vitro Maturation. Cobo A., Castello D., Weiss B., Vivier C., de la Macorra A., Kramp F. //Tokyo.-2011.-P.286.

89. Cobo A./Storage of human oocytes in the vapor phase of nitrogen. Cobo A., Romero J.L., Perz S., de los Santos M.J., Meseguer M., Remohi J. // Fertil. Steril. 2010.-Vol.94.-P.1903-1907.

90. Cobo A./Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Cobo A., Meseguer M., Remohi J., Pellicer A //Hum. Reprod. 2010.-Vol.25.-P.2239-2246.

91. Cobo A./Use of fluorescence in situ hybridization to assess the chromosomal status of embryos obtained from cryopreserved oocytes. Cobo A., Rubio C., Gerli S. et al. //Fertil. Steril. 2001.-Vol. 75.-P.354-360.

92. Cobo A./Vireal screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycels. Cobo A., Bellver J., de los Santos M.J., Remohi J. //Fertil. Steril. -2012.-Vol. 97.-P. 74-78.

93. Coticchio G./ Vitrification ma increase the rate of chromosome misalignment in the metaphase I spindle of human mature oocytes. Coticchio G., Bromfield J. J., Sciajno R. et al. // Reprod. Biomed. Online. 2009; 19(Suppl. 3): 29-34.

94. Daniel Bodri./ Gnrh antafonists in oocyte donor cycles oocyte donor cycles: the key to safe, simple, and efficient stimulation protocols. Doctoral thesis presented by Dr. Daniel Bodri in order to obtain a Ph.D.degree in the doctoral programme of the Department of Gynecology and Paediatrics and Preventive Medicine of the Autonomous University of Barcelona.// Bellatera.2010.

95. Daniel Bodri./Gonadotropin-realising hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors a systematic review and meta-analysis. Daniel Bodri, Sesh Kamal Sunkara Arri Coomarasamy Fertility Sterility 2010 volume 95.- issue 1.- P.164-169.

96. De Leeuw R. /Structure function relationship of recombinant follicule stimulating hormone (Puregon). De leeuw R., Mulders J.,Voortman G. Et al. //Molec.Hum.Reprod.-1996-Vol.2-N5-P.361-369.

97. Decleer W./ A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study. Decleer W., K. Osmanagaoglu, G. Meganck, P. Devroey. //Facts Views Vis. Ob.gyn. 2014.-Vol. 6 (3).-P 159165.

98. Delvigne, A. /Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [Text]. A.Delvigne, S.Rosenberg // Hum Reprod Update. - 2002. - Vol. 8. - P. 559-577.

99. Devroey P./A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Devroey P., Boostanfar R., Koper N.P., Mannaerts B.M., Ijzerman-Boon P.C., Fauser B.C.; ENGAGE Investigators.//Hum. Reprod. -2009 Dec.-Vol.24(12).-P.3063-3072.

100. Devroy P. /Induction of multiple follicular development by single dose of long -acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. Devroy P., Fauser B.C., Platteu P. Et al.// J. Clin. Endocrinol Metab.-2004.-Vol.89(5).-p.2062-2070.

101. Diedrich K./GnRH antagonist. Diedrich K., Ludwig M., Felberbaum R. // In Text-Book - Ovulation induction.-2002.- ELSEVIER.- 171-184.

102. Dix E./ Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. Dix E., Check J.H //Clin. Exp. Obstet. Gynecol.- 2010.-Vol.37.-P.15—16.

103. Ebner T./ Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Ebner T. et al.// Hum.Reprod.2006.- Vol.21.-P.2022-2026.

104. Eichenlaub Ritter U./Manipulation of the oocyte: possible damage to the spindle apparatus. Eichenlaub Ritter U et al. //Reproductive Biomedicine Online.2002.-Vol.5.-P. 117-124.

105. Elisabet Clua./Elective single-embryo transfer in oocyte donation programmes: should it be the rule? Elisabet Clua, Rosa Tur, Buenaventura Coroleu, Montse Boada,I. Rodriguez, Pedro N. Barri, Anna Veiga// Reproductive BioMedicine Online.2012.-Vol.25, 6.-P. 642-648.

106. ELONVA ( corifollitropin alfa) summary of product characteristics. N.V. Organon, a subsidiary of Merck ans Co., Inc., Whitehouse Station, NJ, USA;2010.

107. El-Zibdeh M.Y./ Randomized clinical trial the effecacy of dydrogesteron, human chorionic Gonadotropin or no treatment in the reduction of spontaneous abortion. El-Zibdeh M.Y.//Gynecological endocrinology. The 9th World Congress of Gynecological endocrinology. Hong Kong, December 2-5, 2001.

108. Faby G./Vitrification as an approach to cryopreservation. Faby G., MacFarlane D., Angell C.//Cryobiology.-1984.-Vol.21.-P.407-411.

109. Fadini R./Human oocyte cryopreservation: comparison between slow and ultrarapid methods. Fadini R., Brambillasca F., Renzini M.M., Merola M., Comi R., De Ponti E. et al. //Reprod Biomed Online.- 2009.- Vol.-19.- P.171-180.

110. Fares F.A./ Design of a long - acting follitropin agonist by fusing the c-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Fares F.A., Suganuma N., Nishimori K. Et al.//Proc. Natl. Acad. Sci. USA.- 1992.-Vol.89 (10).-P.4304-4308.

111. Feldschuh J./Successful sperm storage for 28 years. Feldschuh J., Brassel J., Durso N., Levine A. // Fertil. Steril. - 2005. - Vol.84, №4. - P.1017.

112. Ferraretti A./Elective cryopreservation of all oocytes in women at risk of OHSS. Ferraretti A., Gianaroli L., Fasolino M.C. // Hum. Reprod.- 2007.- Vol.22, Suppl. !.-Abstracts Book.- p.100.

113. Garda J.I., Noriega-Portella L., Noriega-Hoces L. /Efficacy of oocyte

vitrification combined with blastocyst stage transfer in an egg donation program. Garda J.I., Noriega-Portella L., Noriega-Hoces L.// Hum.

Reprod. 2011.-Vol.26(4).-P.782-790.

114. Gelbaya, T.A./ The likelihood of live birth and multiple birth after single versus double embryo transfer at the cleavage stage: a systematic review and meta-analysis. T.A. Gelbaya, I. Tsoumpou, L.G. Nardo//Fertil. Steril. - 2010. - Vol. 94, № 3. -P. 936-945.

115. Giuliano M. Bedoschi./Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. Giuliano M. Bedoschi, Felipe Oliveira de Albuquerque, Rui Alberto Ferriani, and Paula Andrea Navarro . // J. Assist. Reprod. Genet. 2010.-Vol.27(8).-P491-494.

116. Gook D./Cryopreservation of mouse and human oocytes using 1,2- propanediol and the configuration of meiotic spindle. Gook D., Osborn S., Johnston W.//Hum. Reprod. 1993.-Vol.8.-P.1101-1109.

117. Griesinger G./GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians second choice. Data from the German national IVF registry. Griesinger G., Felberbaum R. // Hum. Reprod. 2005. - Vol. 20, № 9.-P.2373-2375.

118. Grifo J.A./Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility

preservation for female cancer patients. Grifo J.A., Noyes N. // Fertil.Steril. 2010.- Vol.93.-P.391-396.

119. Guerif F./ Parameters guiding selection of best embryos for transfer after cryopreservation : a reappraisal. Guerif F., Bidault R., Cadoret V. et al./ // Hum. Reprod. 2002.-No 5.-Vol.17 (5). -P.1321-1326.

120. Hardarson T. /The position of the metaphase II spindle cannot be predicted by the location of the first polar body in the human oocyte. Human Reproduction. Hardarson T. // 2000.-Vol. 15.-P. 1372-1376.

121. Hazout et al. /Serum antimullerian hormone/mullerian - inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than FSH, inhibin B, or estradiol. Hazout et al. //Fertil.Steril. 2004.-Vol.82.-P.1323-1329.

122. Hedon B./Efficacy and safety of recombinant FSH in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization : a prospective , randomized assessor-blind , multicenter trial. Hedon B., Out H.J., Hugues J.N. //Hum.Rep.-1995-Vol.10-p.3102-3106.

123. Heijnen E.M./ A mild treatment strategy for in vitro fertilisation and randomised non-inferiority trial randomised trial [Text]/ E.M. Heijnen, M.J. Eijkemans, C. de Klerk // Lancet. - 2007. Vol. 369, Issue 9563.- P.- 743 - 749.

124. Hong S.W./Improved human oocyte development after vitrification: a comparison of thawing methods. Hong S.W., Chung H.M., Lim J.M., Ko J.J., Yoon T.K., Yee B. et al. // Fertil.Steril.- 1999.-VoL.72.-P.142-146.

125. http://www.ivf-worldwide.com/survey/oocyte-donation/results- oocyte-donation.html

126. Humaidan P./GnRHAgonist Triggering Workshop Group GnRH agonist fortriggering of final oocyte maturation: time for a change of practice? Humaidan P., Kol S., Papanikolaou E. // Hum. Reprod. Update. — 2011. — Vol.17. — P. 510-524.

127. Hunter J.E./ Vitrification of human oocytes following minimal exposure to cryoprotectants; initial studies on fertilization and embryonic development. Hunter J.E., Fuller B.J., Bernard A., Jackson A., Shaw R.W. // Hum. Reprod. 1995.-Vol.10.-p.1184-1188.

128. Huser M../Combination of fertility preservation strategies in young women with recently diagnosed cancer. Huser M., Zakova J., Smardova L., Crha I., Janku P., Hudecek R., Ventruba P.//Eur. J. Gynaecol. Oncol.- 2012.- Vol. 33.-P.42-50.

129. Isachenko E.F./Vitrification of mouse germinal vesicle oocytes: effect of treatment temperature and egg yolk on chromatin and spindle normality and cumulus integrity. Isachenko E.F., Nayudu P.L. // Hum. Reprod. 1999.№14.-Vol. 2.-P.400—408.

130. J. L. Gomez-Palomares, M. Chavez, M. A. Manzanares, B. Castro, E. R. Hernandez, E. Ricciarelli. FivMadrid/Comparispn of corifollitropin -alpha vs follitropin-beta in egg donation cycles: a non -inferiority cohort retrospective study. J. L. Gomez-Palomares, M. Chavez, M. A. Manzanares, B. Castro, E. R. Hernandez, E. Ricciarelli. FivMadrid. //Fertil. Steril.2013 - S269.-P.-

422.2013.http://www.fertstert.org/article/S00150282%2813%2901904-3/pdf/

131. Jain J. /Oocyte cryopreservation. Jain J. et al. // Fertil. Steril.- 2005.- 86(4).-P. 1037-46.

132. Jee B.C. /Administration of intravenous albumin around the time of oocyte retrieval reduces pregnancy rate without preventing ovarian hyperstimulation syndrome: a systematic review and meta-analysis[Text]/

B.C. Jee, C.S. Suh, Y.B Kim // Gynecol Obstet Invest. - 2010. - Vol.70, №1. -P. 47-54

133. Jelinkova L./ Twin pregnancy after vitrification of 2 -pronuclei human embryos. Jelinkova L.//Fertil.Steril. 2002.-Vol.77.-P.412-414.

134. Jersus J./Preservation of fertility in patients with cancer. Jersus J., Woodruff T. // N. Engl. J. Med. -2009. -Vol.360- Р. 902-911.

135. Karlsson J.O. /A theoretical model of intracellular devitrification. Cryobiology. Karlsson J.O. // 2001.-42Vol.-P. 154-169.

136. Karrow A.M./Reproductive Tissue Banking: Scientific Principles Karrow A.M., Crister J.K.// Academic Press. - San Diego. - 1997.

137. Katayama K.P. /High survival rate of vitrified human oocytes results in clinical pregnancy. Katayama K.P., Stehlik J, Kuwayama M, Kato O, Stehlik E. // Fertil. Steril. 2003.-Vol.80.-P.223-224.

138. Kazem R./ Cryopreservation of human oocytes and fertilization by two techniques: in-vitro fertilization and intracytoplasmic sperm injection. Kazem R., Thompson L.A., Srikantharajah A., Laing M.A., Hamilton M.P., Templeton A. // Hum. Reprod.- 1995.-Vol.10-P.2650-2654.

139. Keskintepe L./ High survival rate of metaphase II human oocytes after first polar body biopsy and vitrification: determining the effect of previtrification conditions. Keskintepe L., Agca Y., Sher G., Keskintepe M., Maassarani G.// Fertil. Steril.- 2009.-Vol.92.-P.1706-1715.

140. Kim J.H./Efficacy of random-start controlled ovarian stimulation in cancer patients. Kim J.H., Kim S.K., Lee H.J., Lee J.R., Jee B.C., Suh C.S, Kim S.H. // J. Korean Med. Sci. -2015- Mar;30(3).-P.290-295.

141. Kim S./ Breast cancer and fertility preservation. Kim S., Klemp J., Fabian C. // Fertil. Steril. — 2011. — Vol. 95. — P.1535-1543.

142. Kim T. J./Successful live birth from vitrified oocytes after 5 years of cryopreservation. Kim T. J., Hong S.W. // Assist. Reprod. Genet. 2011.-Vol.

28. -P.73-76.

143. Kim T./Pregnancies From Cryopreserved Oocytes Using Vitrification Protocol. Kim T., Hong S., Cha K. // Fertil. Steril.-2005.-Vol.84.-S.179.

144. Kim T.J./Vitrification of oocytes produces high pregnancy rates when carried out in fertile women. Kim T.J., Laufer L.R., Hong S.W. // Fertil. Steril.-2010.-Vol.93.-P.467-474.

145. Klip H./ Cancer risk associated with subfertility and ovulation induction: A review. Klip H., Burger C.W. Kenemans P. // Cancer Causes Control. 2000.-Vol.11 (4).-P.319-344.

146. Kol S. /GnRH agonist triggering: recent developments.// Kol S., Humaidan P. Reprod Biomed Online. 2013.-26(3)-P.226-230.

147. Kol S./ GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy? Kol S., Solt I. // J Assist Reprod Genet.- 2008.- Vol. 25.-P. 63-66.

148. Kol, S./ GnRH agonist triggering: recent developments [Text].S. Kol, P. Humaidan // Reprod. Biomed. Online. - 2013. -Vol.26, Issue 3. -P. 226230.

149. Kuleshova L./ Birth following vitrification of a small number of human oocytes. Kuleshova L., Gianaroli L., Magli C., Ferraretti A., Trounson A.// Hum. Reprod. 1999.-Vol. 14.-P.3077-3079.

150. Kuleshova L.L. /Sugars exert a major influence on the vitrification properties of ethylene glycol-based solutions and have low toxicity to embryos and oocytes. Kuleshova L.L., MacFarlane D.R., Trounson A.O., Shaw J.M. // Cryobiology 1999.-Vol.38: 2.-P.119—130.

151. Kuwayama M. /Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Kuwayama M. et al. //Hum. Reprod. 2011.-Vol.4 (1).-P. 2328.

152. Kuwayama M./Efficiency of the cryotop method to cryopreserve human oocytes; analysis of in vitro and in vivo results at eleven IVF clinics. Kuwayama M., Leibo S.P. // Fetil. Steril. - 2008. - Vol.90. - Suppl.1. - P.S281-S282.

153. Kuwayama M./Highly efficient vitrification method for cryopreservation of human oocytes. Kuwayama M., Vajta G., Kato O., Leibo

5. P.// Reprod. Biomed. Online. 2005.-Vol.11.-P.300-308.

154. Kyono K./ Successful pregnancy and delivery after transfer of a single blastocyst derived from a vitrified mature human oocyte. Kyono K., Fuchinoue K., Yagi A., Nakajo Y., Yamashita A., Kumagai S. //Fertil. Steril. 2005.-Vol.84.-P.1017.

155. L. Garcia De Miguel, M. Caballero Campo, A. Gurria, J. Alonso, A. Serrano, E. Marban, P. Caballero Peregrin. FundacionTambre, Gynecology, Madrid, Spain. Experience on the use of Corifollitropin-alfa (Elonva) for controlled ovarian hyperstimulation in ovum donor cycles http://eshre 13.m.tap.cr/webview/metadata/18117/30825/

156. Lainas T.G./Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase [Text]/T.G. Lainas, I.A. Sfontouris, I.Z. Zorzovilis // Reprod Biomed Online.- 2009.- Vol.19, Issue

6. -P.789-795.

157. Le Lannou /Contribution of embryo cryopreservation to elective single embryo transfer in IVFICSI/ D. Le Lannou [et al.] //Reprod. Biomed. Online. - 2006. - Vol. 13, № 3. - P.368-375.

158. Lee S./American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Lee S., Schover L., Partridge A. et al. // J. Clin. Oncol. 2006.- М. 24.- Р. 2917-2931.

159. Lessey B./ Endometrial integrins and the establishment of uterine receptivity. Lessey B// Human. Reprod. 1998.-Vol.13: 3.P. 247—258.

160. Liebermann J./Cryoloop vitrification in assisted reproduction: analysis of survival rates in > 1000 human oocytes after ultra-rapid cooling with polymer augmented cryoprotectants. Liebermann J., Tucker M.J., Sills E.S. // Obstet. Gynecol. 2003.-Vol.30.-P.125-129.

161. Liebermann J./Potential importance of vitrification in reproductive medicine. Liebermann J., Nawroth F., Isachenko E., Rahimi G., Tucker M. J. //Biol. Reprod. 2002.-Vol.67.-P. 1671-1680.

162. Lopez-Regalado M.L./Randomised clinical trial comparing elective single-embryo transfer followed by single-embryo cryotransfer versus double embryo transfer. Lopez-Regalado M.L., Clavero A., Gonzalvo M.C., Serrano M., Martmez L., Mozas J., Rodriguez-Serrano F., Fontes J., Castilla J.A..// Eur. J. Obstet. Gynecol. Reprod. Biol. 2014.- Jul;178.-P.192-198.

163. Lucena E./ Successful ongoing pregnancies after vitrification of oocytes. Lucena E., Bernal D.P., Lucena C., Rojas A., Moran A., Lucena A. // Fertil. Steril. 2006;85:108-111.

164. Lutjen P./ The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Lutjen P., Trounson A., Leeton J., Findlay J.//1984-vol.307-P.174- 175.

165. Lutjen P.J./Effect on plasma gonadotropins of cyclic steroid replacement in women with premature ovarian failure. Lutjen P.J. , Fidlay J.K., Trounson A.O., Leeton J.F., Cban L.K. // J. Clin. Endocrinol.Metab.- 1986.-Vol.62.-P.419-423.

166. Man A., Schwarz Y./ Pleural effusion as a presenting symptom of ovarian hyperstimulation syndrome. Man A., Schwarz Y. // Europ. Reprod. J.-1997-№10.-P.2425-2426.

167. Mandelbaum J./Cryopreservation of human embryos and oocytes. Mandelbaum J., Junca A.M., Plachot M. et al. // Hum. Reprod. 1988;.-Vol.1 (3).-P. 117-119.

168. Mandelbaum J./Effects of cryopreservation on the meiotic spindle of human oocytes. Mandelbaum J., Anastasiou O., Levy R. et al. // Eur. J. Obstet. Gynecol. Reprod. Biol. 2004.-Vol.113(Suppl.): S17—S23.

169. Manipalviratn S./Clinical application of human oocyte cryopreservation. Manipalviratn S., Decherney A. // Rev. Recent Clin. Trials. 2008.-Vol. 3: 2.-P.104—110.

170. Martinez M./Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. Martinez M., Rabadan S., Domingo J., Cobo A., Pellicer A., Garcia-Velasco J.A.//Reprod. Biomed. Online. 2014.-Vol.29(6).-P.722-728.

171. Maureen J Wood./Vitrification of oocytes. Maureen J Wood. // Obstetrician Gyn. 2012.-Vol. 14.-P.45-49.

172. Mazur P. /Equilibrium qusi-equilibrium and non equilibrium freezing of mammalian embryos. Mazur P. //Cell Biophysiol.-1990-Vol.17.-P.53-58.

173. Melo M. /GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Melo M.// Reprod Biomed Online. - 2009.- Vol.19, Issue 4.-P.486- 492.

174. Merce L.T./Are endometrial parameters by three-dimensional ultrasound and power Dopplerangiography related to in vitro fertilization embryo transfer outcome. Merce L.T., Barco M.J., Bau S., Troyano J. // Fertil. Steril. 2008.-Vol. 89.-P.111—117.

175. Mohamed Abdelfattah Mahmoud Youssef /Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and metaanalysis. Mohamed Abdelfattah Mahmoud Youssef, Madelon van Wely., Ismail Aboulfoutouh, Walid El-Khyat, Fulco van der Veen, Ph.D. and Hesham Al-Inany. // Fertil. Steril.2012- Vol.97-P.876-885.

176. Montfoort A. /Elective single embryo transfer (eSET) policy in the first three IVF/ICSI treatment cycles. Montfoort A., Dumoulin J., Land J. et al. //Human. Reprod. 2005.-Vol.20.-P.433—436.

177. Munoz E./Ovarian stimulation in patients with breast cancer. Munoz E., Gonzalez N., Munoz L., Aguilar J., Velasco J.A. Ovarian //Cancer medical science. 2015 Feb.-Vol.3.-N9.-P.504.

178. Nagy Z. P./Clinical evaluion of the efficiency of an oocyte donation program using egg cryo-banking. Nagy Z. P., Chang C. C., Shapiro D. B., Bernal D. P., Elsner C. W., Mitchell-Leef D. et al. //Fertil. Steril 2009.- Vol.92.-P.520-526.

179. Nargund G. for the Rotterdam ISMAAR Cosensus Group on Terminology for Ovarian Stimulation for IVF[Text] G. Nargund, B.C.J.M. Fauser, N.S. Macklon // Human Reprod Update 2009.

180. Nazzaro A. / rLH supplementation to rFSH during induced ovarian stimulation in the GnRh antagonist protocol improves implantation and pregnancy rates. Nazzaro A., Salerno A., Di Iorrio et al// Hum. Reprod 2013.-Vol.28:S1:465.

181. Noyes N./ Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. Noyes N., Labella P.A., Grifo J., Knopman J.// M.J. Ass. Reprod Genet. 2010;.-Vol.27: 8.-P.495—499.

182. Noyes N./Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Noyes N., Porcu E., Borini A. // Reprod. Biomed. Online. 2009.-Vol.6(18).-P.769-776.

183. Oakley G. P./ Increased prevalence of Downs syndrome among the offspring of women treated with ovulation in ducing agents. Oakley G. P., Flynt J.W. //Teratology.-1972-vol.5-N1-P.264-269.

184. Oktay K. /Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Oktay K., Buyuk E., Libertella N. et al. // J. Clin. Oncol. —2005. — Vol. 23. — P. 4347-4353.

185. Oktay K./Efficiency of oocyte cryopreservation: a meta-analysis. Oktay K., Cil A.P., Bang H. // Fertil Steril 2006.-Vol.86.-P.70-80.

186. Oktay K./Safety of pregnancy after letrozole-FSH stimulation in breast cancer patients: a prospective comparison of frozen embryo transfer to self vs. gestational carriers. Oktay K., Arslan E., Karsy M., Moy F. // Fertil. Steril. — 2011. —Vol. 96. — P. S42-S43.

187. Out H.J/A prospective , randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone in vitro fertilization. Out H.J., Mannaerts B.M.J.L., Driessen S.G.A.J.A //Hum. Rep.- 1995-Vol.5-N10-P.2534-2540.

188. P. Devroey. /A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. P. Devroey, R. Boostanfar, N.P. Koper, B.M.J.L. Mannaerts, P.C. I. Jzerman-Boon, and B.C.J.M. Fauser, on behalf of the ENGAGE Investigators. // Hum. Reprod. 2009.

189. Palomba, S./ Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and metaanalysis of randomised controlled trials [Text]. S. Palomba, A. Falbo, G.B. La Sala // Cochrane Database Syst Rev.

190. Papaleo E./ Effect of myo-inositol on the ovarian response and oocyte quality in PCO patients undergoing ovulation induction for ICSI. Papaleo E., Unfer V. et al. // Hum. Reprod. - 2007. - v.22.- Suppl. 1. - P.89.

191. Papis K. /Factors affecting the survivability of bovine oocytes vitrified in droplets. Papis K., Shimizu M., Izaike Y. // The riogenology 2000.-Vol. 54.-P.651-658.

192. Park S.P. /Ultra-rapid freezing of human multipronuclaer zygotes using electron microscope grids. Park S.P. et al. // Hum. Reprod. 2000.-Vol. 15.-P.1787-1790.

193. Peter R. Brinsden /Superovulation strategies in assisted conception. // Textbook of in vitro fertilization and assisted reproduction. Peter R. Brinsden // Taylor and Francis Group. - 2005.-P. 177-188.

194. Pickering S.J./The influence of cooling on the organization of the meiotic spindle of the mouse oocyte. Pickering S.J., Johnson M.H. //Hum. Reprod. 1987.-Vol.3 (2).-P.207-216.

195. Polak de Fried E. / Pregnancy after human donor oocyte cryopreservation and thawing in association with intracytoplasmic sperm injection in a patient with ovarian failure. Polak de Fried E., Notrica J., Rubinstein M., Marazzi A., Gomez Gonzalez M. // Fertil. Steril. 1998.-Vol.69(3).-P.555-557.

196. Porcu E. /Freezing of oocytes. Porcu E. // Curr. Opin. Obstet. Gynecol. 1999.-Vol. 11.-P.297-300.

197. Potdar N. /Oocyte vitrification in the 21st century and post-warming fertility outcomes: a systematic review and meta-analysis. Potdar N., Gelbaya T.A., Nardo L.G.//Reprod. Biomed. Online. 2014.- Aug.- Vol.29(2):159-176

198. Pouwer A.W./ Long-acting FSH versus daily FSH for women undergoing assisted reproduction (Review). Pouwer A.W., Farquhar C., Kremer J.A.M // The Cochrane Library 2012. -Issue6. http://www.thecochranelibrary.com/

199. PUREGON (rFSH) summary of product characteristics. N.V. Organon, a subsidiary of Merck and Co., Inc., Whitehouse Station, NJ, USA; 2010.

200. Ralf Dittrich. / Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Ralf Dittrich, Laura Lotz, Andreas Mueller, Inge Hoffmann, David L Wachter , Kerstin U Amann, Matthias W Beckmann and Thomas Hildebrandt .//Reproductive Biology and Endocrinology 2013 http: //www.rbej. com/content/11/1/19

201. Rall W. / Ice-free cryopreservation of mouse embryos at -1986C vitriffication. Rall W.,Faby G. //Nature-1985-Vol.313-P.573-575

202. Res U. /Birth after treatment of a male with seminoma and azoospermia with cryopreserved thawed testicular tissue. Res U., Res P., Kastelic D. et al. // Hum. Reprod. - 2000. - Vol.15. - №4. - P.861-864.

203. Rienzi L. /Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Rienzi L., Romano S., Albricci L., Maggiulli R., Capalbo A., Baroni E. et al. // Hum. Reprod. - 2010.-Vol.25.-P.66-73.

204. Rienzi L. /Relationship between meioticspindle location with regard to the polar body position and oocyte developmental potential after ICSI. Rienzi L et al. // Human Reproduction.-2013.-Vol.18.-P. 1289-1293

205. Robert Boostanfar. /A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone. Robert Boostanfar, Bernadette Mannaerts, M.Sc., Samuel Pang, M.D., Manuel Fernandez-Sanchez, M.D.,Han Witjes, Ph.D., and Paul Devroey, M.D., Ph.D.,on behalf of the Engage Investigators .//Fertility and Sterility.-Vol. 97.-№6. June 2012.- h.1351-1358

206. Rosenwaks Z. /Pregnancy following transfer of in vitro fertilized donated oocytes. Rosenwaks Z., Veek L.L., Liu H.C.// Fertil. Steril.-1986.- Vol.45.-P.417-420.

207. Ruiz-Alonso M. /The genomics of the human endometrium. Ruiz- Alonso M., Blesa D., Simon C. //Biochim. Biophys. Acta. - 2012.- Vol.1822.-P.1931—1942.

208. Ruvalcaba L / Improving Donor Programs With An Oocyte Bank Using Vitrification. Ruvalcaba L., Marinez R., Cuneo S., Chanona J, Beltran M, Bermudez A. // Fertil. Steril.- 2005.-Vol.84.-S.70.

209. Rydberg E. /Effect of serum gonadotropin and chroniac gonadotropin on the human ovary. Rydberg E., Pedersen-Bjergaard K // JAMA.-Vol.121- P.1117-1122.

210. Sauer M. / Defining the incidence of serious complications experienced by oocyte donors: A review of 1000 cases. Sauer M.V. //Obstetr. Gynecology.2001.-Vol.184(3).-P.277-278.

211. Sauer M. / Infertility and early pregnancy loss is largely due to oocyte aging, not uterine senescence, as demonstrated by oocyte donation. Sauer M. // Ann. NY Acad. Sci. - 1997. - Vol.828. - P.166-174

212. Scaravelli G. /Analysis of oocyte cryopreservation in assisted reproduction: the Italian National Register data from 2005 to 2007. Scaravelli G., Vigiliano V., Mayorga J.M. et al. //Reprod. Biomed. Online 2010. - Vol. 21.-N.4.-P.496—500.

213. Scbrebier J.R. / Ovarian follicular growth ovulation and atresia. Endocrine, paracrine and autocrine regulation. Scbrebier J.R. // Adv.Exp.Med.Biol.-1995.

214. Schmidt C. /Transfer of cryopreserved-thawed emryos: the natural cycle versus controlled preparation of the endometrium with gonadotropinreleasing hormone agonist and exogenous estradiol and progesterone. Schmidt C., De Ziegler D., Gagliandi C. et al.// Fertil. Steril.- 1989.-Vol. 52:.-P.609-617.

215. Schoolcraft W. /In a highly successeful IVF program, progesteron administered from single daily IM injaction or vaginal progesterone gel applicatios is equally effective at providing luteal support. Schoolcraft W., Hesla J., Gee M. et al. // Presented at the 55th Annual Meeting of the American Society for Repoductive Medicine; Sept. 25.30, Toronto, Canada. Abstract 1999. Serhal P. Oocyte donation and surrogacy. Br Med Bull 1990. - Vol. 46.-P.796-812.

216. Schoolcraft W.B. /Excellent embryo quality obtained from vitrified oocytes. Schoolcraft W.B., Keller J.L., Schlenker T. // Reprod. Biomed. Online 2009.-Vol.19.-P.820-823.

217. Scotland G. /Safety versus in elective single embryo transfer: women’s preferences for outcomes of in vitro fertilization. Scotland G., McNamee P., Peddie V., Bhattacharya S. // BJOG 2007.-Vol.114.-P.977— 983.

218. Segal S. /Progesteron supplementation increases luteal phase endometrial thickness and estradiol levels in-vitro fertilization. Segal S., Casper R.F. // Hum. Reprod. - 1992.-Vol.7.-P.1210-1213.

219. Selman H. / Ongoing pregnancies after vitrification of human oocytes using a combined solution of ethylene glycol and dimethyl sulfoxide. Selman H., Angelini A., Barnocchi N., Brusco G.F., Pacchiarotti A., Aragona C. // Fertil. Steril. 2006.-Vol.86.-P.997-1000.

220. Sher G. /Selective vitrification of euploid oocytes markedly improves survival, fertilization and pregnancy-generating potential. Sher G., Keskintepe L., Mukaida T., Keskintepe M., Ginsburg M., Agca Y.,

Maassarani G., Bayrak A.. //Reprod. Biomed. Online. 2008.-Vol.17.-P.524- 529.

221. Shnecker J.G. /Clinical aspects of ovarian hyperstimulation syndrome. Shnecker J.G. // Eur. J. Obstet. Gynecol. Reprod. Biol. 1999.-Vol.85(1).- P.13-20.

222. Sigismondi C. /Fertility preservation in female cancer patients: a single center experience. Sigismondi C., Papaleo E., Vigano P., Vailati S., Candiani M., Ottolina J., Di Mattei V.E., Mangili G.// Chin J. Cancer. 2015 Jan.-Vol.34(1).-P.56-66.

223. Sismanoglu A./ Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial. Sismanoglu A., Tekin H.I., Erden H.F., Ciray N.H., Ulug U., Bahceci MAssist.// Reprod. Genet. 2009.-26 (5).-P.251-256.

224. Smith A./ Biological effects of freezing and supercooling. Smith A.// № 20. London: Edward Arnold; 1961.

225. Smith G.D. / Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Smith G.D., Serafini P., Fioravanti J., Yadid I., Coslovsky M., Hassun P. et al. //Fertil. Steril. 2010.-Vol. 94.-P.2088-2095.

226. Soares S.R. / Clinical factors affecting endometrial receptiveness in oocyte donation cycles. Soares S.R., Velasco J.A., Fernandez M., Bosch E., Remohi J., Pellicer A., Simon C. // Fertil. Steril. 2008.-Vol. 89.-P.491—501.

227. Soderstrom-Anttila V. / Five years of single embryo transfer with anonymous and non-anonymous oocyte donation. Soderstrom-Anttila V., Vilska S. // Reprod. Biomed. Online. 2007 Oct.-Vol.15(4).-P.428-433.

228. Sole M. /How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes. Sole M., Santalo J., Boada M., Clua E., Rodriguez I., Martmez F., Coroleu B., Barri P.N., Veiga A. // Hum. Reprod. 2013. - Vol.28(8).-P.2087-2092.

229. Stehlik E.J. / Vitrification demonstrates significant improvent versus slow freesing of human blastocysts. Stehlik E.J.// Reprod. Biomed. 2005.- Vol. 11.-P.53-57.

230. Steptoe P.I./Birth after the reimplatation of a human embryo. Steptoe P.I.//Lancet. -1978-Vol.2-P.366.

231. Szekeres-Bartho J. / Progesteron-mediated immunomodulation and anti-abortive effects. The role of the progesterone-induced blocking factor. Gynecological endocrinology. The 9th World Congress of Gynecological endocrinology. Szekeres-Bartho J. // Hong Kong. - December 2-5. - 2001.

232. Tao T. /Human oocyte cryopreservation. Tao T., Zhang W., Del Valle A. // Curr. Opin. Obstet. Gynecol. 2009.-Vol. 3.-P.247-252.

233. Thomas J. Kim / Successful live birth from vitrified oocytes after 5 years of cryopreservation. Thomas J. Kim, Seung Wook Hong //Assist. Reprod. Genet. 2011- Vol.28-P.73-76.

234. Trounson A. / Preservation of human eggs and embryos. Trounson A. //Fertil. Steril.-1986.-Vol.46.-P.11-12

235. Trounson A. /Human pregnancy following cryopreservation, thawing and transfer of an eight cell embryo. Trounson A., Mohr L. //Nature. - 1983. - Vol.305. - P. 707-709.

236. Vajta G. / Improving cryopreservation systems. Vajta G., Kuwayama M. // Theriogenology. 2006.-Vol. 65. -P.236-244.

237. Van Blerkom J. /Oocyte dismorphism and aneuploidy in meiotically mature human oocytes after ovarian stimulation. Van Blerkom J., Henry G.H. // Human Reproduction. 1992-Vol.7.-P.379-390.

238. Van den Abbeel E. / Osmotic responses and tolerance limits to changes in external osmolalities,and oolemma permeability characteristics, of human in vitro matured MII oocytes. Van den Abbeel E., Schneider U., Liu J., Agca Y., Critser J.K., Van Steirtherghem A. // Human Reproduction. 2007. -Vol. 22.-P.1959-1972.

239. Van Steirteghem A. / Pregnancy with a frozen-thawed embryo in a woman with primary ovarian failure. Van Steirteghem A., Van den Abbeel E., Braeckmans P. et al. // N. Engl. J. Med. 1987.-P.313-317.

240. Van Uem J./Birth after cryopreservation of human oocytes. Van Uem J., Siebzebnrubl E., Scbub B., Kocb R., Trotnow S //Lancet.-Vol.1.-P.752

241. Vanderzwalmen P. / Septic vitrification of blastocyst from infertile patients, egg donors and after IVM. Vanderzwalmen P., Ectors F., Grobet L., Prapas Y., Panagiotidis Y., Vanderzwalmen S., et al. // Reprod. Biomed. Online. 2009.-Vol. 19.-P.700-707.

242. Venetis, C.A./Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis. [Text]/ C.A. Venetis [et al.]// Fertil Steril.- 2011.- Vol.95, №1, P.-188-196.

243. Von Wolff M. / Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network Von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B.//Arch Gynecol Obstet 2011, 284:427-435.

244. Von Wolff M. /Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Von Wolff M., Thaler C., Frambach T. et al. // Fertil. Steril. —2009. — Vol. 92. — P. 1360-1365.

245. W. Decleer / A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study. W. Decleer, K. Osmanagaoglu G. Meganck, P. Devroey //Facts Views Vis Obgyn. 2014.-Vol. 6 (3).-P. 159-165.

246. Wallace W. /Predicting age of ovarian failure after radiation to a field that in-cludes the ovaries. Wallace W., Thomson A., saran F., Kelsey T. // int. J. Radiat. oncol. biol. Phys. — 2005. — Vol. 62. — P. 738-744.

247. Wang W.H. /Limited recovery of meiotic spindles in living human oocytes after cooling-rewarming observed using polarized light microscopy. Wang W.H. et al. // Human Reproduction.2001.-Vol.16.-P.2374-2378.

248. Wang W.H./The spindle observation and its relationship with fertilization after intracytoplasmic sperm injection in living human oocytes. Wang W.H.//Fertility and Sterility.2001.-Vol 75.-P.348-353.

249. Wikland M. / Obstetric outcomes after transfer of vitrified blastocyst. Wikland M. // Hum. Reprod. 2010. -Vol. 25(7).-P.1699-1707.

250. Winslow K. /Oocyte cryopreservation a three year follow up of sixteen births. Winslow K., Yang D., Blohm P. et al. // Fertil. Steril. 2001. - Vol.-76(3).-P.120-121.

251. Wolff M. /Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Wolff M., Thaler C.J., Frambach T., Zeeb C., Lawrenz B., Popovici R.M., Strowitzki T. // Fertil Steril. 2009.-Vol.92.-P.1360-1365. doi: 10.1016/j.fertnstert.2008.08.011

252. Yoon T. /Pregnanacy and delivery of healthy infants developed from vitrified oocytes in stimulated in vitro fertilization-embryo transfer program. Yoon T., Chung H. // Fertile. Steril. 2000-Vol.74.-P.180-181.

253. Yoon T.K. /Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Yoon T.K., Kim T.J., Park S.E., Hong S.W, Ko J.J., Chung H.M et al. // Fertil. Steril. 2003.-Vol.79.-P.1323- 1326.

254. Yoon T.K./ Survival rate of human oocytes and pregnancy outcome after vitrification using slush nitrogen in assisted reproductive technologies.

Yoon T.K., Lee D.R., Cha S.K., Chung H.M., Lee W.S., Cha K.Y. // Fertil. Steril. 2007.-Vol.88.-P.952-956.

255. Youssef, M.A. /Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome [Text]. M.A. Youssef //Cochrane Database Syst Rev. - 2011.- Vol. 16, Issue 2:CD001302.

256. Zhang X., Chen C.H., Confino E., Barnes R., Milad M., Kazer R.R. /Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Zhang X., Chen C.H., Confino E., Barnes R., Milad M., Kazer R.R. //Fertil. Steril. 2005.-Vol.83.-P.336—340.

257. Ziebe S. / Arce for the MERIT ( Menotropin recombinant FSH in vitro Fertilisation Trial) Group Influence of ovarian stimulation with HP- hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Ziebe S., Kersti lundin K., Janssens R. et al //Hum. Reprod. 2007.-Vol.22.-N.9.-P.2404-2413.

153